PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF MALARIA THERAPEUTICS
$2,088,140N01FY2018AINIH
Duke University, Durham NC
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.
View original record on NIH RePORTER →